150 likes | 246 Views
Suggested guidelines for appropriate patient selection for patients undergoing Accelerated Partial Breast Irradiation at DMC. Tonya Echols Cole, MD. Patient Evaluation. Multidisciplinary; before surgery Breast Surgeon Radiation Oncologist Medical Oncologists. Types of APBI. Interstitial
E N D
Suggested guidelines for appropriate patient selection for patients undergoing Accelerated Partial Breast Irradiation at DMC. Tonya Echols Cole, MD
Patient Evaluation • Multidisciplinary; before surgery • Breast Surgeon • Radiation Oncologist • Medical Oncologists
Types of APBI • Interstitial • Intraoperative • Electron • 50 Kv • Balloon cavitary • Mammosite • Contura • Savi • External Beam • 3D conformal • IMRT
Current Guidelines- Old • ASBS - 2005 • ABS - 2007 • European Collaborative Group - 2009 • ACRO - 2008 • ASTRO- 2009
Additional Studies • At least 5 randomized trials • Short follow-up • Outdated or nonstandard technique • Lack of power • At least 41 non randomized trials • Many with at least 10 year follow-up
Clinical Trial Results • ASBS Mammosite Registry Trial • 44 month follow-up on first 400 cases. • Cancer specific survival of 100% • Local recurrence rate between 0-2.65% • DCIS Phase II Clinical Study • 15 month follow-up on 100 patients • 3% local recurrence rate
Retrospective review of 330 analytic cases of breast cancer treated with accelerated partial breast irradiation from 2006 to present Accelerated Partial Breast Radiation Recurrence rate study(QI 2013 4-6)Tonya Echols Cole, Md& TerrI Richardson, RHIA,CTR 330 APBI procedure 72% (239) were invasive 28% (91) were DCIS
Recurrences • 14 total recurrences ( 4.2%) • 7 Local (2.1%) • 3 Regional (0.9%) • 4 Distant (1.2%) • Median time to recurrence was 53 months
Local Recurrences • 7 local recurrences 2.1% recurrence rate All patients were >50 yrs. old All tumors <3cm • 3 were DCIS or 3/91 or 3.3% • 2 of the 3 did not take Tamoxifen (pt. refusal or medically contraindicated.) • All were ER+ • 4 were invasive 4/239 or 1.7% • 1 was triple negative 2 were triple +
Regional Recurrences • 3 regional recurrences 3/330 ( 0.9%) • All invasive cancer <3cm • All >60 yrs. old • 2 were triple -, 1ER+, Her2+ • All had 3 lymph nodes examined
Distant recurrences • 4 Distant recurrences 4/330 (1.2%) • 75% ¾ were invasive • All >50 yrs. old • All tumors <3cm • All were ER+ • All received hormonal therapy • 1 received chemotherapy • 25% (1/4) DCIS • Was ER -
Conclusions • Local recurrence rates for patients treated with accelerated partial breast radiation therapy at DMC are comparable to published data. • There was no group or subset found to be at increased risk of recurrence.
Acceptable • Age > 50 • Size < 3 cm • Histology All invasive subtypes and DCIS • ER Positive or negative • Margins Negative • LVI Not present • Nodal status negative
Not acceptableOutside of a clinical Trial Microscopically multifocal >3cm EIC > 3cm Margins + Nodal surgery- not performed. BRCA + • Node positive • Tumors > 3cm including DCIS • Extensive LVSI • Neoadjuvant chemo • Age <45 • Multicentric
Future Directions • Recommendations should be updated annually as new results from prospective randomized trials are released.